Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Anxiety: Overview01:18

Anxiety: Overview

Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
Social Anxiety Disorder01:28

Social Anxiety Disorder

Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2020
Same author

Neural substrates of cue reactivity and craving in gambling disorder.

Translational psychiatry·2017
Same author

Homological scaffolds of brain functional networks.

Journal of the Royal Society, Interface·2014
Same author

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.

Psychological medicine·2014
Same author

A case of reversal of treatment-resistant depression after almost 30 years of symptoms: Case Reports.

International journal of psychiatry in clinical practice·2014
Same author

Sedative antidepressants impair visual detection mechanisms in humans.

Journal of psychopharmacology (Oxford, England)·2012
Same journal

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Mitochondrial dysfunction in schizophrenia and its modulation by atypical antipsychotic drugs: A randomized controlled trial.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Effects of pimavanserin, xanomeline and highly-purified plant-derived cannabidiol on MK-801-induced behaviours in mice relevant to psychosis.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants.

Journal of psychopharmacology (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

The anxiety factor in depression.

D Nutt1

  • 1Director, Psychopharmacology Unit, University of Bristol, Bristol, UK.

Journal of Psychopharmacology (Oxford, England)
|February 3, 2012
PubMed
Summary
This summary is machine-generated.

Sertraline, a selective serotonin re-uptake inhibitor (SSRI), effectively treats anxiety symptoms in depression. It offers comparable efficacy to clomipramine with a better side-effect profile and no anxiety aggravation, making it a valuable treatment option.

Related Experiment Videos

Last Updated: May 25, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Area of Science:

  • Psychiatry
  • Clinical Pharmacology

Background:

  • Anxiety symptoms frequently co-occur with depression, negatively impacting patient outcomes.
  • Serotonergic dysfunction is a key factor in anxiety development.
  • Selective serotonin re-uptake inhibitors (SSRIs) are recognized for their efficacy in managing anxiety.

Purpose of the Study:

  • To evaluate the efficacy and safety of sertraline in treating anxiety symptoms associated with depression.
  • To compare sertraline's therapeutic profile with other antidepressants, including clomipramine and other SSRIs.

Main Methods:

  • Review of existing studies on sertraline's effectiveness in anxiety disorders and depression.
  • Comparative analysis of sertraline's efficacy and side-effect profile against clomipramine and fluoxetine.
  • Assessment of sertraline's impact on sleep disturbances in depressed patients.

Main Results:

  • Sertraline demonstrates significant efficacy in reducing anxiety symptoms in depression, comparable to clomipramine.
  • Sertraline exhibits a more favorable side-effect profile than clomipramine, with fewer cardiovascular issues and dropouts.
  • Unlike fluoxetine, sertraline does not appear to aggravate anxiety symptoms and normalizes sleep disturbances without causing daytime sedation.

Conclusions:

  • Sertraline is a beneficial therapeutic option for managing anxiety symptoms in patients with depression.
  • Its comparable efficacy, improved safety profile, and lack of anxiety aggravation support its use over other treatments.
  • Sertraline offers a valuable treatment strategy for the high prevalence of anxiety in depressive disorders.